The Agribody Technologies Team: Our experienced, technically diverse and highly efficient team has more than 225 combined years of directly relevant experience in their respective specialty areas.  Details of each Executive’s career and education follow.

John Thompson, Ph.D. - Chief Scientist / Co-Founder

  • University of Waterloo (Emeritus Professor, Associate VP Research)
  • Invented eIF5A/DHS technology
  • Extensively published, cited and patented
  • B.S. (Toronto), Ph.D. (Alberta), Fellow of Royal Society of Canada

Alan Bennett, Ph.D. - Chair SAB

  • UC-Davis (Professor of Plant Science)
  • Transformed/characterized elite alfalfa with eIF5A
  • Runs advanced genetics lab
  • Extensively published, cited and patented
  • B.S. (UC-Davis), Ph.D. (Cornell)

Vaughn Smider, M.D., Ph.D. - Advisor

  • CSO of Sevion Therapeutics, Founder/President of its precursor company, Fabrus.
  • Associate Professor at The Scripps Research Institute in protein engineering
  • Leadership Council for American Cancer Society
  • B.A (Hiram College), M.D. & Ph.D. (Stanford U.)

Craig Williams - Field Trials / Regulatory

  • 25 years experience managing seed companies
  • Knowledgeable in seed business operations, regulatory affairs, field trials, M&A due diligence
  • B.S. (Bradley U.)

Jerry Caulder, Ph.D. - Advisor

  • Known as the “Father of Agricultural Biotechnology”
  • After 15 years with Monsanto, lead Mycogen as CEO to build a $1.2 Bil valuation.
  • Lead 2 other companies before becoming Chair of Athenix, sold for $400 Mil.
  • Founded Finistere Ventures
  • B.S. (SE Missouri State U.), Ph.D. (U. Missouri)

Jim Goode - Acting CFO

  • 35 years managing financial/admin functions of small-medium growth companies
  • Raised >$100 Mil for clients, acquisitions, global business & turnarounds
  • Provided part-time CFO services for >20 years in high-tech, biotech and start-ups
  • MBA valedictorian (UCLA), CPA (Arthur Young)

Jerry Feitelson, Ph.D. - CEO / Co-Founder

  • 30 years industrial R&D, IP, Licensing, Bus Dev & entrepreneurial experience
  • Managed $10 Mil/year royalty revenues; Negotiated $7 Mil license
  • Patented B.t. genes/proteins partially leading to ~$850 Mil IP valuation at Mycogen
  • Co-founder/early employee at 3 ag biotech companies
  • B.S. (MIT), Ph.D (Stanford), NIH Postdoc (John Innes Institute, UK)

Executive Team

Consultants / Advisors

Paul Kreutz - Counsel

  • Practiced law in SF Bay Area from 1967-1994; built Gray Cary’s office in San Diego
  • Represented many VC firms:  Enterprise Partners, Forward Ventures, etc.
  • Counsels & helps structure growth-oriented entrepreneurial enterprises
  • B.A. (Yale), LL.B. (Stanford)